Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
27m agoUPDATED NOTICE REGARDING THE PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS
27m agoLondon's Top Restaurants Named at Inaugural OpenTable Awards, Including New 'Icons'
27m agoeDreams ODIGEO Exceeds Subscriber Growth Target by 5% and Reaches 7.9 Million Prime Members
52m agoSmithfield Foods Reports Record First Quarter Fiscal 2026 Results
52m agoETC’s Aerospace and Commercial/Industrial Units Awarded Contracts of Approximately $37 Million
Kane Biotech Inc logo

Kane Biotech Inc

About

Kane Biotech Inc (V:KNE) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
Apr 16 2026
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
Apr 16 2026
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
Mar 17 2026
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
Mar 10 2026
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

Financials

Revenue
CA$574.87 K
Market Cap
CA$5.02 M
EPS
0.00

Community Chat

Ask AI

6ix6ix